Blue Owl Capital L.P. 13F annual report
Blue Owl Capital L.P. is an investment fund managing more than $359 billion ran by Karen Hager. There are currently 38 companies in Mrs. Hager’s portfolio. The largest investments include Cullinan Therapeutics Inc and Pliant Therapeutics, together worth $68 billion.
$359 billion Assets Under Management (AUM)
As of 8th August 2024, Blue Owl Capital L.P.’s top holding is 2,049,172 shares of Cullinan Therapeutics Inc currently worth over $35.7 billion and making up 10.0% of the portfolio value.
In addition, the fund holds 3,004,199 shares of Pliant Therapeutics worth $32.3 billion, whose value fell 22.0% in the past six months.
The third-largest holding is Blue Owl Capital Corporation worth $31.4 billion and the next is Klaviyo Inc worth $29.8 billion, with 1,198,270 shares owned.
Currently, Blue Owl Capital L.P.'s portfolio is worth at least $359 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Blue Owl Capital L.P.
The Blue Owl Capital L.P. office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Karen Hager serves as the Chief Compliance Officer at Blue Owl Capital L.P..
Recent trades
In the most recent 13F filing, Blue Owl Capital L.P. revealed that it had opened a new position in
Context Therapeutics Inc and bought 5,161,290 shares worth $10.3 billion.
The investment fund also strengthened its position in Tourmaline Bio Inc by buying
268,000 additional shares.
This makes their stake in Tourmaline Bio Inc total 1,715,401 shares worth $22.1 billion.
On the other hand, there are companies that Blue Owl Capital L.P. is getting rid of from its portfolio.
Blue Owl Capital L.P. closed its position in Robinhood Mkts Inc on 15th August 2024.
It sold the previously owned 4,237,409 shares for $54 billion.
Karen Hager also disclosed a decreased stake in Cullinan Therapeutics Inc by 0.3%.
This leaves the value of the investment at $35.7 billion and 2,049,172 shares.
One of the smaller hedge funds
The two most similar investment funds to Blue Owl Capital L.P. are Bernardo Wealth Planning and Axs Investments. They manage $359 billion and $359 billion respectively.
Karen Hager investment strategy
Blue Owl Capital L.P.’s portfolio is diversified across 5 sectors.
Currently, their heaviest sector is Health Care — making up 28.6% of
the total portfolio value.
The fund focuses on investments in the United States as
42.1% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
13% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $1.43 billion.
The complete list of Blue Owl Capital L.P. trades based on 13F SEC filings
These positions were updated on August 15th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Robinhood Mkts Inc |
Closed
4,237,409
|
$53,984,591,000 | |
| Cullinan Therapeutics Inc |
29.94%
2,049,172
|
$35,737,560,000 | 9.97% |
| Pliant Therapeutics, Inc. |
No change
3,004,199
|
$32,295,139,000 | 9.01% |
| Blue Owl Capital Corporation |
No change
2,045,070
|
$31,412,275,000 | 8.76% |
| Klaviyo Inc |
No change
1,198,270
|
$29,824,940,000 | 8.32% |
| Larimar Therapeutics, Inc. |
3.38%
3,859,468
|
$27,981,143,000 | 7.80% |
| Engene Holdings Inc |
0.47%
2,449,827
|
$23,101,869,000 | 6.44% |
| Tourmaline Bio Inc |
18.52%
1,715,401
|
$22,060,057,000 | 6.15% |
| Evercommerce Inc |
No change
1,641,929
|
$18,028,381,000 | 5.03% |
| Acelyrin Inc |
3.54%
2,926,028
|
$12,903,783,000 | 3.60% |
| Repare Therapeutics Inc. |
8.01%
3,372,499
|
$11,129,247,000 | 3.10% |
| Ultragenyx Pharmaceutical In |
No change
268,238
|
$11,024,582,000 | 3.07% |
| Context Therapeutics Inc |
Opened
5,161,290
|
$10,348,386,000 | 2.89% |
| Disc Medicine Inc |
38.64%
215,260
|
$9,701,768,000 | 2.71% |
| Toast, Inc. |
No change
322,578
|
$8,312,835,000 | 2.32% |
| E2open Parent Holdings Inc |
No change
1,650,943
|
$7,412,734,000 | 2.07% |
| Keros Therapeutics, Inc. |
8.69%
157,633
|
$7,203,828,000 | 2.01% |
| Ikena Oncology Inc |
5.14%
4,091,118
|
$6,750,345,000 | 1.88% |
| Sagimet Biosciences Inc |
No change
1,673,877
|
$5,724,659,000 | 1.60% |
| Mineralys Therapeutics Inc |
16.77%
450,339
|
$5,268,966,000 | 1.47% |
| Viking Therapeutics Inc |
Opened
95,000
|
$5,035,950,000 | 1.40% |
| Moonlake Immunotherapeutics |
Closed
100,000
|
$5,023,000,000 | |
| Inozyme Pharma, Inc. |
11.81%
1,120,027
|
$4,995,320,000 | 1.39% |
| Dell Technologies Inc |
Closed
41,245
|
$4,706,467,000 | |
| Starwood Property Trust Inc |
Opened
226,456
|
$4,289,077,000 | 1.20% |
| Direxion Shs Etf Tr |
Closed
490,000
|
$3,572,100,000 | |
| Madrigal Pharmaceuticals Inc |
Closed
13,319
|
$3,556,706,000 | |
| Black Diamond Therapeutics I |
Closed
695,000
|
$3,523,650,000 | |
| Pyxis Oncology Inc |
Opened
1,046,025
|
$3,462,343,000 | 0.97% |
| Mereo BioPharma Group plc |
Opened
897,809
|
$3,232,112,000 | 0.90% |
| Aquestive Therapeutics Inc |
30.29%
1,140,000
|
$2,964,000,000 | 0.83% |
| Compass Therapeutics Inc |
No change
2,829,712
|
$2,829,712,000 | 0.79% |
| Ovid Therapeutics Inc |
Closed
864,822
|
$2,637,707,000 | |
| Starwood Property Trust Inc |
Closed
116,153
|
$2,361,390,000 | |
| ADC Therapeutics SA |
No change
733,568
|
$2,318,075,000 | 0.65% |
| Omega Therapeutics Inc |
No change
1,055,882
|
$2,185,676,000 | 0.61% |
| Structure Therapeutics Inc |
Opened
55,000
|
$2,159,850,000 | 0.60% |
| Immunovant Inc |
20.00%
80,000
|
$2,112,000,000 | 0.59% |
| Syros Pharmaceuticals Inc. |
No change
340,855
|
$1,758,812,000 | 0.49% |
| Janux Therapeutics Inc |
Opened
40,000
|
$1,675,600,000 | 0.47% |
| Snowflake Inc. |
Closed
7,819
|
$1,263,550,000 | |
| GitLab Inc. |
Closed
20,706
|
$1,207,574,000 | |
| Celcuity Inc |
Opened
65,000
|
$1,064,700,000 | 0.30% |
| Blend Labs, Inc. |
No change
361,587
|
$853,351,000 | 0.24% |
| GoHealth, Inc. |
No change
83,264
|
$814,631,000 | 0.23% |
| Desktop Metal, Inc. |
Closed
750,000
|
$660,000,000 | |
| Rallybio Corp |
Closed
350,240
|
$647,944,000 | |
| Enliven Therapeutics Inc |
Closed
25,000
|
$439,750,000 | |
| Desktop Metal, Inc. |
Opened
750,000
|
$309,750,000 | 0.09% |
| Fathom Digital Mfg Corp |
Closed
50,000
|
$230,500,000 | |
| Precision BioSciences, Inc. |
No change
20,220
|
$196,741,000 | 0.05% |
| Geron Corp. |
Opened
23,918
|
$101,412,000 | 0.03% |
| Geron Corp. |
Closed
23,918
|
$78,929,000 | |
| No transactions found | |||
| Showing first 500 out of 53 holdings | |||
Hedge funds similar to Blue Owl Capital L.P.
- New World Advisors
- Shay Capital
- Lifeworks Advisors
- Genworth Inc
- Gardner Lewis Asset Management L P
- Axs Investments
- Bernardo Wealth Planning
- Paradigm Asset Management Co
- Hnp Capital
- Cic Wealth
- Ellsworth Advisors
- Sage Advisory Services, Co
- L.m. Kohn & Company
- Crestview Partners Iii Gp, L.P.